Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Int J Mol Sci ; 17(7)2016 Jul 21.
Artigo em Inglês | MEDLINE | ID: mdl-27455240

RESUMO

Intravenous iron preparations are typically classified as non-dextran-based or dextran/dextran-based complexes. The carbohydrate shell for each of these preparations is unique and is key in determining the various physicochemical properties, the metabolic pathway, and the immunogenicity of the iron-carbohydrate complex. As intravenous dextran can cause severe, antibody-mediated dextran-induced anaphylactic reactions (DIAR), the purpose of this study was to explore the potential of various intravenous iron preparations, non-dextran-based or dextran/dextran-based, to induce these reactions. An IgG-isotype mouse monoclonal anti-dextran antibody (5E7H3) and an enzyme-linked immunosorbent assay (ELISA) were developed to investigate the dextran antigenicity of low molecular weight iron dextran, ferumoxytol, iron isomaltoside 1000, ferric gluconate, iron sucrose and ferric carboxymaltose, as well as isomaltoside 1000, the isolated carbohydrate component of iron isomaltoside 1000. Low molecular weight iron dextran, as well as dextran-based ferumoxytol and iron isomaltoside 1000, reacted with 5E7H3, whereas ferric carboxymaltose, iron sucrose, sodium ferric gluconate, and isolated isomaltoside 1000 did not. Consistent results were obtained with reverse single radial immunodiffusion assay. The results strongly support the hypothesis that, while the carbohydrate alone (isomaltoside 1000) does not form immune complexes with anti-dextran antibodies, iron isomaltoside 1000 complex reacts with anti-dextran antibodies by forming multivalent immune complexes. Moreover, non-dextran based preparations, such as iron sucrose and ferric carboxymaltose, do not react with anti-dextran antibodies. This assay allows to assess the theoretical possibility of a substance to induce antibody-mediated DIARs. Nevertheless, as this is only one possible mechanism that may cause a hypersensitivity reaction, a broader set of assays will be required to get an understanding of the mechanisms that may lead to intravenous iron-induced hypersensitivity reactions.


Assuntos
Dextranos/análise , Dextranos/imunologia , Ensaio de Imunoadsorção Enzimática/métodos , Ferro/química , Ferro/imunologia , Administração Intravenosa , Animais , Anticorpos Monoclonais/imunologia , Imunização , Ferro/administração & dosagem , Camundongos , Camundongos Endogâmicos BALB C
2.
Methods Enzymol ; 436: 255-72, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18237637

RESUMO

The use of the heterologous bacterial hemoglobin (VHb) from Vitreoscilla to enhance growth and productivity of Escherichia coli under conditions of oxygen limitation has been one of the foremost examples of metabolic engineering. Although VHb has earned its merits during the last two decades by providing enhanced physiological enhancements to organisms from all kingdoms of life, it has been the candidate of choice primarily for historical reasons. Findings made during the last years, however, suggest that hemoglobin and flavohemoglobin proteins from bacterial species other than Vitreoscilla or artificially generated mutant proteins or fusion variants of hemoglobins and flavohemoglobins may be better suited for use in biotechnological processes. This account provides guidelines for the assessment of biotechnologically relevant characteristics conferred by such novel heterologous hemoglobins and flavohemoglobins in E. coli.


Assuntos
Proteínas de Bactérias/biossíntese , Proteínas de Bactérias/isolamento & purificação , Hemoglobinas Truncadas/biossíntese , Hemoglobinas Truncadas/isolamento & purificação , Proteínas de Bactérias/genética , Reatores Biológicos , Biotecnologia , Western Blotting , Meios de Cultura , Escherichia coli/genética , Escherichia coli/crescimento & desenvolvimento , Escherichia coli/metabolismo , Flavina-Adenina Dinucleotídeo/metabolismo , Expressão Gênica , Genes Bacterianos , Heme/metabolismo , Oxigênio/metabolismo , Plasmídeos/genética , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/genética , Proteínas Recombinantes/isolamento & purificação , Espectrofotometria , Hemoglobinas Truncadas/genética , Vitreoscilla/química , Vitreoscilla/genética
3.
J Biotechnol ; 122(2): 161-75, 2006 Mar 23.
Artigo em Inglês | MEDLINE | ID: mdl-16290305

RESUMO

Bacterial hemoglobins and flavohemoglobins have been used to improve cell growth and productivity in biotechnological applications. The expression of globin genes can be induced by reducing the oxygen supply or applying external stressors, which provide a simple and inexpensive mechanism for induction of heterologous protein production. It is in the interest of the biotechnological industry to seek new promoters, which are non-patented, cheap and simple to induce. Therefore, new globin gene promoters have been isolated from Campylobacter jejuni, Bacillus subtilis, Deinococcus radiodurans, Streptomyces coelicolor, and Salmonella typhi. The goal was to obtain insights about the regulation mechanisms of these promoters in Escherichia coli using in silico and experimental methods. The recognition of these promoters by the E. coli transcriptional machinery was first analyzed by computational methods. Computer analysis revealed that all the promoters, except the promoter of S. coelicolor, should be functional in E. coli and most of them also contain putative binding sites for ArcA, CRP, and FNR global regulators. Furthermore, the expression profiles of the promoters fused to the chloramphenicol acetyl transferase gene were analyzed under various conditions using E. coli mutants devoid of regulatory molecules. In vivo regulation studies of globin promoters mainly verified the in silico predictions.


Assuntos
Di-Hidropteridina Redutase/biossíntese , Proteínas de Escherichia coli/biossíntese , Escherichia coli/metabolismo , Regulação Bacteriana da Expressão Gênica , Engenharia Genética , Hemeproteínas/biossíntese , Hemoglobinas/biossíntese , NADH NADPH Oxirredutases/biossíntese , Regiões Promotoras Genéticas/genética , Bactérias/genética , Carboidratos/farmacologia , Biologia Computacional , Di-Hidropteridina Redutase/genética , Escherichia coli/genética , Proteínas de Escherichia coli/genética , Proteínas de Escherichia coli/metabolismo , Hemeproteínas/genética , Hemoglobinas/genética , Proteínas Ferro-Enxofre/metabolismo , NADH NADPH Oxirredutases/genética , Regiões Promotoras Genéticas/efeitos dos fármacos
4.
FEMS Microbiol Lett ; 224(1): 127-32, 2003 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-12855179

RESUMO

The Vitreoscilla hemoglobin gene (vhb) is expressed under oxygen-limited conditions via an FNR-dependent mechanism. Furthermore, cAMP-CRP has been implicated in its regulation. Recently, VHb protein has been reported to protect a heterologous host from nitrosative stress. In this study we analyzed the regulation of the Vitreoscilla hemoglobin promoter (Pvhb) in Escherichia coli under nitrosative and oxidative stress conditions. Our results show unambiguously that expression of neither VHb nor chloramphenicol acetyltransferase under the control of Pvhb is induced under the experimental conditions used. Thus, a clear discrepancy between in vivo function, i.e. protection against nitrosative stress, and regulation of gene expression is obvious. The regulation of Pvhb reported here is in clear contrast to the expression pattern of flavohemoglobins from various microorganisms, which are generally induced by nitrosative stress. However, the length of Pvhb is only 146 bp and therefore, we cannot rule out that additional regulatory sequences may be located in the upstream region of Pvhb.


Assuntos
Proteínas de Bactérias/genética , Escherichia coli/genética , Escherichia coli/metabolismo , Hemoglobinas/genética , Estresse Oxidativo/fisiologia , Cloranfenicol O-Acetiltransferase/genética , Regulação Bacteriana da Expressão Gênica , Nitrogênio/metabolismo , Plasmídeos , Regiões Promotoras Genéticas/fisiologia , Hemoglobinas Truncadas
5.
Arch Microbiol ; 189(4): 385-96, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18043907

RESUMO

The regulation of flavohemoglobin expression is complex and depending on its host organism requires a wide variety of different transcriptional regulators. In Pseudomonas aeruginosa, the flavohemoglobin (Fhp) and its cognate regulator FhpR form an NO-sensing and detoxifying system regulated by their common bidirectional promoter Pfhp/PfhpR. The intergenic fhp-fhpR region of P. aeruginosa PAO1 was used as a bait to isolate proteins affecting the transcription of fhp and fhpR. In addition to the FhpR, we identified two previously uncharacterized P. aeruginosa proteins, PA0779 and PA3697. Both PA0779 and PA3697 were found to be essential for NO3(-) and NO2(-) induced Pfhp activity under aerobic and low-oxygen conditions, and needed for the full function of Pfhp/PfhpR as NO responsive regulatory circuit under aerobic conditions. In addition, we show that the transcriptional activity of PfhpR is highly inducible upon addition of SNP under aerobic conditions, but not by NO3(-), NO2(-) or under low-oxygen conditions, supporting the findings that FhpR is not the only factor affecting flavohemoglobin expression in P. aeruginosa.


Assuntos
Proteínas de Bactérias/genética , Regulação Bacteriana da Expressão Gênica , Genes Reguladores , Hemeproteínas/genética , Regiões Promotoras Genéticas , Pseudomonas aeruginosa/genética , Transcrição Gênica , Proteínas de Bactérias/química , Proteínas de Bactérias/isolamento & purificação , Proteínas de Bactérias/metabolismo , Sequência de Bases , Hemeproteínas/metabolismo , Dados de Sequência Molecular , Mutação , Nitritos/metabolismo , Oxigênio/metabolismo , Pseudomonas aeruginosa/metabolismo , Alinhamento de Sequência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA